Panel Discussion: Leveraging Cross-Sector Partnerships: How Small Biotechs Navigate Big Pharma Interest in Dermatology

• What data packages de-risk acquisition or licensing for large pharma?
• How do biotechs time interactions with BD teams and investment banks?
• What distinguishes “interesting science” from investable clinical programs? 

Speakers:

Serena Mandla

Cso

Noa Therapeutics

Laurent Jacqueroud

Senior Director, Business Development Dermatology & Respiratory Diseases

Glenmark Pharmaceuticals